Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 1258 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich 2017-09-20
Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich 2017-09-18
Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London 2017-09-18
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
Silence Therapeutics–FTI Consulting: public relations, 201707 service existent by FTI Consulting 2017-07-14
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
BioCity (GB)–Alto Marketing: public relations, 201707 service existent for BioAscent Discovery Ltd by Alto Marketing Ltd 2017-07-11
Freeline Therapeutics–Consilium: public relations, 201707 service existent by CSC 2017-07-10
Cellnovo–Consilium: public relations, 201707 service existentPR in UK by CSC 2017-07-07
Cobalt Light Systems–Agilent: investment, 201707 acquisition by Agilent for £40m in cash 2017-07-07
Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors 2017-07-06
GSK–Exscientia: drug discovery, 201707– strategic collab pre-clinical research on up to 10 GSK targets 2017-07-02
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
LogicBio Therapeutics–Arix Bioscience: investment, 201706 financing round Series B totalling $45m incl lead investor Arix Bioscience 2017-06-27
LogicBio Therapeutics–LCF Rothschild: investment, 201706 financing round Series B totalling $45m incl new + co-investor EdRIP 2017-06-27
LogicBio Therapeutics–SEVERAL: investment, 201706 financing round Series B $45m led by Arix Bioscience + incl OrbiMed +EdRIP + Pontifax + SBI 2017-06-27
Mitoconix Bio–Arix Bioscience: investment, 201706 financing round Series A totalling $20m incl co-investor Arix Bioscience 2017-06-27
Mitoconix Bio–SEVERAL: investment, 201706 financing round Series A $20m led by Remiges Ventures + incl OrbiMed + Arix Bioscience + RMPG et al 2017-06-27
Electrical Geodesics–Philips: investment, 201706– acquisition £29m in cash of EGI by Philips for £1.054/share ANNOUNCED 2017-06-22
Evotec–Deutsche Bank: investor conference, 201706 supply service Evotec presents at dbAccess Berlin Conference 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Cell Medica–United Kingdom (govt): T cell therapy, 201706– acquisition rights €na to WT1-TCR cell therapy from CGT Catapult 2017-06-20
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Novacyt–SEVERAL: investment, 201706 capital increase €3m net €2.8m w 3.53m new shares resulting in delution of 16% 2017-06-20
Parexel–Pamplona Capital: investment, 201706– acquisition $5b incl net debt in cash with $88.1/share ANNOUNCED 2017-06-20
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Biocartis–MRC Technology: molecular diagnostics, 201706– collab €na developm of liquid biopsy cancer tests on Idylla platform 2017-06-07
Cosmo Pharmaceuticals–Leucadia: investor conference, 201706 supply service Cosmo attends Jefferies Global Healthcare Conference 2017 in NY 2017-06-07
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Arix Bioscience–Leucadia: investor conference, 201706 supply service Arix Bioscience presents at Jefferies Healthcare Conference in New York 2017-06-06
Cell Medica–Leucadia: investor conference, 201706 supply service Cell Medica presents at Jefferies Healthcare Conference in New York 2017-06-06
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab to develop 5 bispecific antibodies incl lead asset FS118 2017-06-04
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Arix Bioscience–Consilium: public relations, 201705 service existent by Consilium Strategic Communications 2017-05-31
Oxford Gene Technology–Sysmex: investment, 201705– acquisition €na of OGT by Sysmex 2017-05-31
Recipharm–Ramarketing: public relations, 201705 service existent by Ramarketing 2017-05-26
Harpoon Therapeutics–Arix Bioscience: investment, 201705 financing round Series B totalling $45m incl new + co-lead investor Arix Bioscience plc 2017-05-25
Harpoon Therapeutics–SEVERAL: investment, 201705 financing round Series B $45m Arix Bioscience + New Leaf Venture + Taiho Ventures + MPM Capital 2017-05-25
AstraZeneca–Genomic Vision: genomic technology, 201705– collab using FiberVision DNA combing to develop WEE1 kinase inhibitors 2017-05-23
CureVac–Informa: investor conference, 201705 supply service CureVac presents at BioEquity Europe 2017 in Paris 2017-05-22
Evotec–Informa: investor conference, 201705 supply service Evotec presents at BioEquity Europe 2017 in Paris 2017-05-22
Medigene–Informa: investor conference, 201705 supply service Medigene presents at BioEquity Europe 2017 in Paris 2017-05-22
Probiodrug–Informa: investor conference, 201705 supply service Probiodrug presents at BioEquity Europe 2017 in Paris 2017-05-22
Recordati–AstraZeneca: metoprolol, 201705– acquisition $300m commercial rights to Seloken + Logimax in Europe by Recordati 2017-05-22
TxCell–Informa: investor conference, 201705 supply service TxCell presents at BioEquity Europe 2017 in Paris 2017-05-22
Iterum Therapeutics–Arix Bioscience: investment, 201705 financing round Series B totalling $65m incl new + lead investor Arix Bioscience plc 2017-05-19
Iterum Therapeutics–SEVERAL: investment, 201705 financing round Series B $65m led by new investor Arix Bioscience plc 2017-05-19
Scancell–SEVERAL: investment, 201705 placing £5m (net £4.7m) of 50.5m shares at 10p/share 2017-05-11
BC Platforms–Debiopharm: investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–SEVERAL: investment, 201705 financing round Series B $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–Tesi (FI): investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
Exscientia–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-09
GammaDelta–Takeda: investment, 201705 equity investment as part of strategic collab incl excl option to acquire GammaDeltaTherapeutics 2017-05-09
Sanofi–Exscientia: drug discovery, 201705– strategic research collab up to €250m using AI for bi-specific small-moleulces for metabolic disease 2017-05-09
Takeda–GammaDelta: T cell therapy, 201705– strategic collab $100m funding by Takeda + Abingworth incl equity investm + option to acquire GDT 2017-05-09
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705– acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG ANNOUNCED 2017-05-08
Luxendo–Bruker Corp: investment, 201705 acquisition €na of Luxendo GmbH by Bruker 2017-05-08
United Kingdom (govt)–Fluidigm: mass cytrometry, 201705 supply 7 Helios mass cytometry systems to new MRC Consortium for Mass Cytometry 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
AstraZeneca–Pieris: anticalin technology, 201705– collab developm + commerc $57.5m upfront + near-term inhaled respiratory drugs incl PRS-060 2017-05-03
Z Factor–SEVERAL: investment, 201705 financing round Series A £7m led by exising investor Medicxi 2017-05-03
Adaptimmune–Deutsche Bank: investor conference, 201705 supply service Adaptimmune presents at Deutsche Bank Annual Health Care Conference 2017-05-02
Ultromics–Univ Oxford: investment, 201705 seed funding from Oxford Sciences Innovation 2017-05-01
Microsaic–SCPA GmbH: chromatography software, 201704– collab integration of 4000 MiD MS system with PrepCon 5 preparative data + control s/w 2017-04-26
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Enamine–Zyme Communications: public relations, 201704 service existent by Zyme 2017-04-25
Advent France Biotechnology–Advent Venture Partners: fund management, 201704 service existent support by Advent Life Sciences 2017-04-20
Advent France Biotechnology–SEVERAL: investment, 201704 first closing €64.75m of Advent France Biotechology Seed-Fund I 2017-04-20
ThromboGenics–Bicycle Therapeutics: small-molecule drugs, 201704 collab existent r+d of bicycle peptides for eye diseases 2017-04-20
Hookipa Biotech–Instinctif Partners: public relations, 201704 service existent by Instinctif Partners 2017-04-19
Cobra Biologics–Zyme Communications: public relations, 201704 service existent by Zyme 2017-04-18
Endo International–SEVERAL: credit, 201704–2024 senior secured notes $300m at 5.875% due 2024 to refinance existing debt 2017-04-12
HiberGene–Exitus Communications: public relations, 201704 service existent by Exitus 2017-04-12
Optibrium–Lhasa: cheminformatics, 201704– collab r+d in drug metabolism modelling 2017-04-11
Consilium–Westwicke Partners: public relations, 201704– collab joint venture for healthcare-focused US IR advisory 2017-04-10
Mérieux–Huntsworth: public relations, 201704 service existent for Transgene SA by Citigate Dewe Rogerson 2017-04-10
Asceneuron–Instinctif Partners: public relations, 201704 service existent by Instinctif Partners 2017-04-06
MGB Biopharma–SEVERAL: investment, 201704 financing round $1.15m from existing investors led by Archangel Investors Ltd 2017-04-06
Adaptimmune–Matrix Capital Management: investment, 201704 direct offering $42m of 7m ADSs at $6/ADS 2017-04-05
SkinBioTherapeutics–Instinctif Partners: public relations, 201704 service existent by Instinctif Partners 2017-04-05
Verona Pharma–SEVERAL: investment, 201704 US IPO $78m with 5.768m ADSs at $13.5/ADS at Nasdaq Global Market 2017-04-04
Adaptimmune–Leucadia: investor conference, 201703 supply service Adaptimmune presents at Jefferies Immuno-Oncology Summit in Boston 2017-03-30
Novartis–Oxford BioMedica: lentiviral vector technology, 201703 supply existent OBM sole producer of lentiviral vector expressing CTL019 2017-03-30
Redx Pharma–CARB-X: grant, 201703– grant $1m over 18 months to advance candidates for drug resistant Gram-negative bacteria 2017-03-30
PureTech Health–Novartis: investment, 201703 equity position in new resTORbio subsidary for Novartis as part of mTORC1 inhibitor license deal 2017-03-24
PureTech Health–Novartis: mTORC1 inhibitors, 201703– license excl to 2 clin stage programs to be developed by new resTORbio subsidary 2017-03-24
Agalimmune–BioLineRx: investment, 201703 acquistion $3m cash upfront + $3m shares + milestones of Agalimmune by BioLineRx 2017-03-23
Numares–Univ Oxford: NMR-based IVD tests, 201703– collab developm of multiple sclerosis test using Axinon IVD system + MGS technology 2017-03-23
Adaptimmune–SEVERAL: investment, 201703 public offering $60.06m+$5.88m net $61.8m with 14.3m+1.4m ADSs at $4.2/ADS 2017-03-21
Prothena–Oppenheimer: investor conference, 201703 supply service Prothena presents at Oppenheimer Annual Healthcare Conference in New York 2017-03-21
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px